140 related articles for article (PubMed ID: 37190142)
1. Survival Outcomes and Failure Patterns in Patients with Inoperable Non-Metastatic Pancreatic Cancer Treated with Definitive Radiotherapy.
Cao B; Zhang L; Wu C; Liu X; Wang Q; Tong F; Yang W; Wang J
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190142
[TBL] [Abstract][Full Text] [Related]
2. Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy.
Chen YL; Tsai CL; Cheng JC; Wang CW; Yang SH; Tien YW; Kuo SH
Front Oncol; 2021; 11():730646. PubMed ID: 35070957
[TBL] [Abstract][Full Text] [Related]
3. Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer.
Reyngold M; O'Reilly EM; Varghese AM; Fiasconaro M; Zinovoy M; Romesser PB; Wu A; Hajj C; Cuaron JJ; Tuli R; Hilal L; Khalil D; Park W; Yorke ED; Zhang Z; Yu KH; Crane CH
JAMA Oncol; 2021 May; 7(5):735-738. PubMed ID: 33704353
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer.
Jethwa KR; Sannapaneni S; Mullikin TC; Harmsen WS; Petersen MM; Antharam P; Laughlin B; Mahipal A; Halfdanarson TR; Merrell KW; Neben-Wittich M; Sio TT; Haddock MG; Hallemeier CL
J Gastrointest Oncol; 2020 Dec; 11(6):1408-1420. PubMed ID: 33457010
[TBL] [Abstract][Full Text] [Related]
5. Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive Surgery.
Dee EC; Ng VC; O'Reilly EM; Wei AC; Lobaugh SM; Varghese AM; Zinovoy M; Romesser PB; Wu AJ; Hajj C; Cuaron JJ; Khalil DN; Park W; Yu KH; Zhang Z; Drebin JA; Jarnagin WR; Crane CH; Reyngold M
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731159
[No Abstract] [Full Text] [Related]
6. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
7. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system.
Tringale KR; Tyagi N; Marsha Reyngold ; Romesser PB; Wu A; O'Reilly EM; Varghese AM; Godoy Scripes P; Khalil DN; Park W; Yu K; Crane CH
Phys Imaging Radiat Oncol; 2022 Oct; 24():88-94. PubMed ID: 36386447
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
10. [Long-term outcomes and failure patterns of definitive radiotherapy for cervical esophageal carcinoma].
Liu X; Luo JW; Zhou ZM; Wu RY; Zhang Y; Wang K; Chen XS; Qu Y; Huang XD; Wang X; Bi N; Feng QF; Lyu JM; Chen DF; Xiao ZF; Xiao JP; Yi JL; Gao L
Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1125-1131. PubMed ID: 36319459
[No Abstract] [Full Text] [Related]
11. Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer.
Shi W; Jiang R; Liang F; Yu G; Long J; Zhao J
Cancer Manag Res; 2019; 11():5065-5073. PubMed ID: 31213918
[No Abstract] [Full Text] [Related]
12. Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.
Golden DW; Novak CJ; Minsky BD; Liauw SL
Radiat Oncol; 2012 Sep; 7():156. PubMed ID: 22974515
[TBL] [Abstract][Full Text] [Related]
13. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
14. Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience.
Lang K; Baur M; Held T; Shafie RE; Moratin J; Freudlsperger C; Zaoui K; Bougatf N; Hoffmann J; Plinkert PK; Debus J; Adeberg S
Radiol Oncol; 2021 Nov; 55(4):467-473. PubMed ID: 34821134
[TBL] [Abstract][Full Text] [Related]
15. Limitations of conventional doses of chemoradiation for unresectable biliary cancer.
Crane CH; Macdonald KO; Vauthey JN; Yehuda P; Brown T; Curley S; Wong A; Delclos M; Charnsangavej C; Janjan NA
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):969-74. PubMed ID: 12095564
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity.
Miszczyk M; Kraszkiewicz M; Moll M; Kaminiów K; Sobel S; Dolla Ł; Wojcieszek P; Rajwa P; Yanagisawa T; Nowicka Z; Shariat SF; Goldner G; Miszczyk L; Majewski W
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831523
[TBL] [Abstract][Full Text] [Related]
17. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer.
Rudra S; Jiang N; Rosenberg SA; Olsen JR; Roach MC; Wan L; Portelance L; Mellon EA; Bruynzeel A; Lagerwaard F; Bassetti MF; Parikh PJ; Lee PP
Cancer Med; 2019 May; 8(5):2123-2132. PubMed ID: 30932367
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy.
Du XX; Yu R; Wang ZF; Du DC; Liu QY; Wang RM; Kang SR; Yang H
Bosn J Basic Med Sci; 2019 May; 19(2):186-194. PubMed ID: 30877837
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
